THERAPEUTIC USE OF BACILLUS PRODIGIOSUS IN THE USSR

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP80-00809A000700090462-8
Release Decision: 
RIPPUB
Original Classification: 
U
Document Page Count: 
1
Document Creation Date: 
December 22, 2016
Document Release Date: 
August 10, 2011
Sequence Number: 
462
Case Number: 
Publication Date: 
December 3, 1952
Content Type: 
REPORT
File: 
AttachmentSize
PDF icon CIA-RDP80-00809A000700090462-8.pdf57.38 KB
Body: 
Sanitized Copy Approved for Release 2011/08/11 :CIA-RDP80-00809A000700090462-8 CENTRAL INTELLIGENCE AGENCY INFORMATInN FROM REPORT FOREIGN DOCUMENTS OR RADIO BROADCASTS CD NO. COUNTRY ~gR SUBJECT Scientific - Medicine, aatibietics HOW Military _ BW PUBLISHED Monthly periodical WHERE PUBLISHED Moscov DATE PUBLISHED Jun 1952 LANGUAGE Russian DATE OF INFORMATION 1952 DATE DIST. ~ DEC 1952 N0. OF PAGcS 1 SUPPLEMENT TO REPORT N0. THIS IS UNEVALUATED INFORMATION Nauka i ybiyn_~ Vol XIX, No 6, 1952, p 34. THERAPEUTIC USE OF BACILLUS PRODIGIOSUS IN THE USSR A. M. Bezborodov marcescen]thaveibeenocoaductediia Russieopsiaces1886B? In mgt yew, ~e Fatia Gamaleya for the first time investigated thoroughly the properties oP this microorganism. In 1887, A, D. Pavlovskiy published an article in which he des- cribed the results of his experiments on using B, prodigiosue to treat the cu- taneous form of anthrax is rabbits. I:. 1894, N. P. Tishutkin submitted a dis- sertation in which the action of B. prodigiosue on Achorion [Trichophyto] Fungi which cause mange was described, Other Russian investigators; including 0. Ling, also studied the properties of B, prodigiosue. However, the greatest successes in the application of this microorganism in both human and veterinary medicine were achieved during the Soviet period. A group directed by Prof B, I. Kurochkin utilized B, prodigiosue for the active suppression oT Staph, aureus and applied B. prodigiosue in the treatment of open suppurating wounds. In a liquid nutrient medium, Bacilli prodigiosi kill 2.5 times their quantity of staphylococci within one minute. D. prodigiosue is also used Por the treatment oP persons who carry diph_ theria bacilli. As a rule, people who have recovered Prom diphtheria remain carriers of bacilli for a long time. However, the maJority of'diphtheria bacilli carriers (93.2y6) arc rid of thr causative Factor of this disease entirely within 2 weeks if ~ suspension of B, prodigiosue is dropped into their nose and pharynx, The pigment of B, prodigiosue, prodigiosin, has a considerable antibiotic activity, It suppresses Staph, aureus and can be used as an effective remedy, USSR scientists have investigated B, prodigiosue only Por the purpose of treating diseases. On the other hand, the Germans, during the occupation of Paris in World War II, used B, prodigiosue ae a test organism is Paris subways and at the Place de la Concorde in investigating procedures Por biological war- fare, CLASSIFICATION FOR 0~'F1ClA! llSE ONlY Sanitized Copy Approved for Release 2011/08/11 :CIA-RDP80-00809A000700090462-8